Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15594-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CDCA3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CDCA3 antibody (Cat. #15594-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Comprehensive bioinformatics analysis and cell line experiments revealed the important role of CDCA3 in sarcoma.
Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway.
CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma.
The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma.
CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3.
CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.
Li Y, Wu Z, Ding T, Zhang W, Guo H, Huang F
Heliyon 2024 Jul 15;10(13):e32785
Heliyon 2024 Jul 15;10(13):e32785
Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway.
Liu F, Zhu C, Ma H, Yang Q
Naunyn-Schmiedeberg's archives of pharmacology 2024 Jan;397(1):109-122
Naunyn-Schmiedeberg's archives of pharmacology 2024 Jan;397(1):109-122
CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma.
Bai Y, Liao S, Yin Z, You B, Lu D, Chen Y, Chen D, Wu Y
Journal of oncology 2022;2022:6343760
Journal of oncology 2022;2022:6343760
The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma.
Shen D, Fang Y, Zhou F, Deng Z, Qian K, Wang G, Xiao Y, Ju L, Wang X
Cancer cell international 2021 May 12;21(1):257
Cancer cell international 2021 May 12;21(1):257
CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
Wang X, Dong J, Li X, Cheng Z, Zhu Q
Oncogene 2021 Jun;40(25):4338-4351
Oncogene 2021 Jun;40(25):4338-4351
miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3.
Chen Q, Zhou L, Ye X, Tao M, Wu J
Pathology, research and practice 2020 Apr;216(4):152872
Pathology, research and practice 2020 Apr;216(4):152872
CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.
Zhang W, Lu Y, Li X, Zhang J, Zheng L, Zhang W, Lin C, Lin W, Li X
Biochemical and biophysical research communications 2018 Jun 2;500(2):196-203
Biochemical and biophysical research communications 2018 Jun 2;500(2):196-203
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CDCA3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CDCA3. This antibody recognizes human antigen. The CDCA3 antibody has been validated for the following applications: ELISA, WB analysis.
